Faculty profile
Maureen McKeague
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Publisher Correction: Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.
Nature chemistry · 2026
Protocol for detecting in vitro riboswitch conformational switching using a fluorescence anisotropy single-stranded RNA-targeting approach.
STAR protocols · 2026
Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.
Nature chemistry · 2026
Latest funding
- $500,000
Canada Research Chair - Tier 2
CIHR · 2023 · Nominated PI
- $105,000
Developing Differentiation Regulators for Acute Myeloid Leukemia using RNA Therapeutics
CIHR · 2023 · Supervisor
- $726,751
Small activating RNAs targeting transcription factors as a therapeutic approach for acute myeloid leukemia
CIHR · 2022 · Nominated PI
24 publications.
Publisher Correction: Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.
Saliba D, Osman EA, Elmanzalawy A, Saab C, Bui S, Hirka S, Anderson S, Toader V, Dore MD, Rizzuto FJ, de Rochambeau D, McKeague M, Sleiman HF
Protocol for detecting in vitro riboswitch conformational switching using a fluorescence anisotropy single-stranded RNA-targeting approach.
Clairoux A, Rivera M, McKeague M, Mittermaier A
Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.
Saliba D, Osman EA, Elmanzalawy A, Saab C, Bui S, Hirka S, Anderson S, Toader V, Dore MD, Rizzuto FJ, de Rochambeau D, McKeague M, Sleiman HF
Current landscape of mRNA therapeutics for acute myeloid leukemia.
Hamed M, Kovecses O, McKeague M
Tunable gene expression in zebrafish using RiboSCALE.
Rynes TP, Osman EA, McKeague M, Mruk K
From Selection to Use: Aptamers as Targeting Reagents in Hematology.
Albert B, Ebanks F, Gharagozloo K, Hai X, Ngu R, Munting S, McKeague M
One size does not fit all: A comparative framework for optimizing ribonucleic acid transfection across acute myeloid leukemia cell lines.
Kojic MM, Spencer C, Kovecses O, McKeague M
Fluorescence Anisotropy Applied to Measure Aptamer-Protein Interactions.
Rivera M, McKeague M
Aptamer Engineering: Strategies for Discovering Functional Nucleic Acids for Next-Generation Diagnostics and Biosensing.
Nguyen JVL, Meziadi A, Brunner C, McKeague M, Malic L, Tabrizian M
RNA activation of CEBPA improves leukemia treatment.
Kovecses O, Sharif-Askari B, Gonzalez-Losada C, Reebye V, Ryan BM, Luedtke NW, Mercier FE, McKeague M
Canada Research Chair - Tier 2
Principal investigators: McKeague, Maureen H
Keywords: Crc
Developing Differentiation Regulators for Acute Myeloid Leukemia using RNA Therapeutics
Principal investigators: Kovecses, Olivia
Keywords: Acute Myeloid Leukemia; Differentiation Therapy; Nucleic Acid Therapeutics; Personalized Medicine; Small Activating Rna; Transcription Factor Networks
Small activating RNAs targeting transcription factors as a therapeutic approach for acute myeloid leukemia
Principal investigators: McKeague, Maureen H; Luedtke, Nathan; Mercier, François
Keywords: Acute Myeloid Leukemia; Drug Delivery; Drug Design; Drug Development; Lipid Nanoparticles; Rna Activation; Rna Chemistry; Rna Expression; Therapeutic Oligonucleotides
Quantification of physical and chemical characteristics of cells and bioparticles using flow cytometry
Principal investigators: Tabrizian, Maryam
Predictive Biomarkers for Efficacy of Cytarabine in Acute Myeloid Leukemia Therapeutics
Principal investigators: Maru, Bruktawit
Keywords: Acute Myeloid Leukaemia; Cytarabine Anabolism; Drug Sensitivity Modulation; Nucleic Acid Therapy; Parp1; Predictive Biomarkers; Rna Activation; Therapeutic Oligonucleotides
Real-time insights into molecular recognition and biological mechanisms
Principal investigators: Mckeague, Maureen
Functional nucleic acids for green biosynthesis
Principal investigators: Mckeague, Maureen
Functional nucleic acids for green biosynthesis
Principal investigators: Mckeague, Maureen
Canada Research Chair - Tier 2
Principal investigators: McKeague, Maureen H
Keywords: Crc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Nicolas Moitessier and Anthony Mittermaier: 8 shared papers
- Maureen McKeague and Anthony Mittermaier: 2 shared papers
- Sabrina Leslie and Maureen McKeague: 1 shared paper
- Maryam Tabrizian and Maureen McKeague: 1 shared paper
- Nicolas Moitessier and Maureen McKeague: 1 shared paper
- Chemistry
- Pharmacology and Therapeutics
- Biomedical Engineering
- Physics
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.